Suppr超能文献

胰高血糖素样肽-1(7-36)和艾塞那肽-4对链脲佐菌素/烟酰胺诱导的糖尿病大鼠血管反应性的影响。

Effect of glucagon-like peptide-1(7-36) and exendin-4 on the vascular reactivity in streptozotocin/nicotinamide-induced diabetic rats.

作者信息

Ozyazgan Sibel, Kutluata Nilüfer, Afşar Selim, Ozdaş Sule Beyhan, Akkan Ahmet Gökhan

机构信息

Department of Pharmacology and Clinical Pharmacology, Istanbul University, Cerrahpasa Faculty of Medicine, Istanbul, Turkey.

出版信息

Pharmacology. 2005 Jun;74(3):119-26. doi: 10.1159/000084277. Epub 2005 Mar 3.

Abstract

We investigated the vascular effects of glucagon-like peptide-1 (GLP-1) and Exendin-4 in type 2 diabetic rat aortae. Studies were performed in a normal control group (NC) (0.2 ml i.p. saline, n = 10), streptozotocin (STZ)/nicotinamide diabetic control group (DC) (a single dose of 80 mg/kg STZ i.p. injection 15 min after administration of 230 mg/kg nicotinamide i.p.), GLP-1 (GLPC) control group (1 microg/kg twice daily i.p. for 1 month, n = 10), Exendin-4 control group (EXC) (0.1 microg/kg twice daily i.p. for 1 month, n = 10), GLP-1-treated diabetic group (GLPT) (1 microg/kg twice daily i.p. for 1 month, n = 10), and Exendin-4-treated diabetic group (EXT) (0.1 microg/kg twice daily i.p. for 1 month, n = 10). One month of GLP-1 and Exendin-4 treatment significantly decreased the blood glucose levels of diabetic rats (113 +/- 2 mg/dl, p < 0.001, and 117 +/- 1 mg/dl, p < 0.001, respectively versus 181 +/- 9 mg/dl in the DC group). Sensitivity (pD2) and maximum response (% Max. Relax) of acetylcholine-stimulated relaxations in the DC group (pD2: 6.73 +/- 0.12 and 55 +/- 6, respectively) were decreased compared with the non-diabetic NC group (pD2: 7.41 +/- 0.25, p < 0.05, and 87 +/- 4, p < 0.01). Treating diabetic rats with GLP-1, pD2 values and with Exendin-4, Max. Relax %values of aortic strips to acetylcholine returned to near non-diabetic NC values (pD2: 7.47 +/- 0.15, p < 0.05, and 87 +/- 3, p < 0.01, respectively). Maximal contractile responses (Emax) to noradrenaline in aortic strips from the diabetic DC group (341 +/- 27 mg tension/mg wet weight) were significantly decreased compared with the non-diabetic NC (540 +/- 66 mg tension/mg wet weight, p < 0.001) and the GLPT group (490 +/- 25 mg tension/mg wet weight, p < 0.05). There were no significant differences in pD2 values of aortic strips to noradrenaline from all groups. Emax to KCl in aortic strips from the DC group (247 +/- 10 mg tension/mg wet weight, p < 0.01) was significantly decreased compared with non-diabetic NC group (327 +/- 26 mg tension/mg wet weight). Treating diabetic rats with GLP-1 (GLPT), Emax values of aortic strips to KCl returned to near non-diabetic NC values (271 +/- 12 mg tension/mg wet weight). GLP-1 and (partially) Exendin-4 treatment could improve the increased blood glucose level and normalize the altered vascular tone in type 2 diabetic rats.

摘要

我们研究了胰高血糖素样肽 -1(GLP -1)和艾塞那肽 -4对2型糖尿病大鼠主动脉的血管效应。实验在正常对照组(NC)(腹腔注射0.2 ml生理盐水,n = 10)、链脲佐菌素(STZ)/烟酰胺糖尿病对照组(DC)(腹腔注射230 mg/kg烟酰胺15分钟后,腹腔注射单剂量80 mg/kg STZ)、GLP -1对照组(GLPC)(每天腹腔注射两次,每次1 μg/kg,共1个月,n = 10)、艾塞那肽 -4对照组(EXC)(每天腹腔注射两次,每次0.1 μg/kg,共1个月,n = 10)、GLP -1治疗糖尿病组(GLPT)(每天腹腔注射两次,每次1 μg/kg,共1个月,n = 10)和艾塞那肽 -4治疗糖尿病组(EXT)(每天腹腔注射两次,每次0.1 μg/kg,共1个月,n = 10)中进行。GLP -1和艾塞那肽 -4治疗1个月后,糖尿病大鼠的血糖水平显著降低(分别为113±2 mg/dl,p < 0.001和117±1 mg/dl,p < 0.001,与DC组的181±9 mg/dl相比)。与非糖尿病NC组相比,DC组乙酰胆碱刺激的舒张反应的敏感性(pD2)和最大反应(%最大舒张)降低(pD2:分别为6.73±0.12和55±6)(NC组pD2:7.41±0.25,p < 0.05;%最大舒张:87±4,p < 0.01)。用GLP -1治疗糖尿病大鼠,主动脉条对乙酰胆碱的pD2值恢复到接近非糖尿病NC组的值(pD2:7.47±0.15,p < 0.05);用艾塞那肽 -4治疗,主动脉条对乙酰胆碱的最大舒张%值恢复到接近非糖尿病NC组的值(87±3,p < 0.01)。糖尿病DC组主动脉条对去甲肾上腺素的最大收缩反应(Emax)(341±27 mg张力/mg湿重)与非糖尿病NC组(540±66 mg张力/mg湿重,p < 0.001)和GLPT组(490±25 mg张力/mg湿重,p < 0.05)相比显著降低。所有组主动脉条对去甲肾上腺素的pD2值无显著差异。DC组主动脉条对氯化钾的Emax(247±10 mg张力/mg湿重,p < 0.01)与非糖尿病NC组(327±26 mg张力/mg湿重)相比显著降低。用GLP -1治疗糖尿病大鼠(GLPT),主动脉条对氯化钾的Emax值恢复到接近非糖尿病NC组的值(271±12 mg张力/mg湿重)。GLP -1和(部分)艾塞那肽 -4治疗可改善2型糖尿病大鼠升高的血糖水平,并使改变的血管张力恢复正常。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验